Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001571049-14-004550
Filing Date
2014-09-11
Accepted
2014-09-11 16:40:44
Documents
2
Period of Report
2014-09-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1401766_barker-f3.html 3  
1 OWNERSHIP DOCUMENT t1401766_barker-f3.xml 3 1611
2 EXHIBIT 24 t1401766_ex24.htm EX-24 8523
  Complete submission text file 0001571049-14-004550.txt   11609
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 51 AUNT MOLLY ROAD HOPEWELL NJ 08525
Business Address
BARKER SAM L (Reporting) CIK: 0001226877 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 141098507